Abstract: Methods, compositions, and articles of manufacture for alkane activation with single- or bi-metallic catalysts on crystalline mixed oxide supports.

Abstract: Disclosed is a buffer component and a pressing device, the buffer component is applied to the pressing device. The pressing device includes an anisotropic conductive film pressure knife, the buffer component includes an inserting part, which is made of a first elastic material, and the inserting part is configured to insert into a lower end of the anisotropic conductive film pressure knife; and a buffering part, which is made of a second elastic material, the buffering part is configured to closely attach to a lower end surface of the lower end of the anisotropic conductive film pressure knife.

Abstract: The present disclosure relates to a method for preparing a haemostatic composition comprising thrombin, the method comprising the step of reconstituting a dry thrombin directly in a paste, such as a paste comprising a biocompatible polymer. The haemostatic composition comprising thrombin may be prepared from a dry thrombin composition and a paste in a single step operation and be used for treatment of a wound.

Abstract: Methods, compositions, and articles of manufacture for alkane activation with single- or bi-metallic catalysts on crystalline mixed oxide supports.

Abstract: A method and an apparatus for detecting a micro short circuit of a battery are provided. The detection method includes: obtaining a first reference charge capacity at a first charging end moment and a second reference charge capacity at a second charging end moment of a to-be-detected single battery included in a to-be-detected battery pack (S201), where the reference charge capacity is a difference between an electric quantity of the to-be-detected single battery and an electric quantity of a reference single battery, and the reference single battery is a single battery, which has a largest voltage value at a charging end moment, in all single batteries included in the to-be-detected battery pack; and determining, based on a difference between the first reference charge capacity and the second reference charge capacity, that a micro short circuit occurs in the to-be-detected single battery.

Abstract: A fast charging method, a fast charging system, and a fast charging apparatus for a series battery pack, where the fast charging method including obtaining charge parameters of battery units in a series battery pack, determining, based on the charge parameters, whether there is a differentiated battery unit in the series battery pack, where the differentiated battery unit is a battery unit whose charge parameter is different from a charge parameter of the rest battery units in the series battery pack, and changing the battery units in the series battery pack to a parallel connection when there is a differentiated battery unit in the series battery pack, and performing parallel charging on the battery units. Hence, the fast charging method for a series battery pack can effectively shorten a charging time.

Abstract: A fast charging method for a parallel battery pack is provided, including: obtaining a maximum charging current allowed by a charging trunk and a charging current required for charging a parallel battery pack; comparing the charging current required for charging the parallel battery pack with the maximum charging current allowed by the charging trunk; if the charging current required for charging the parallel battery pack is less than or equal to the maximum charging current allowed by the charging trunk, performing parallel charging on battery units; or if the charging current required for charging the parallel battery pack is greater than the maximum charging current allowed by the charging trunk, changing some or all of battery units in the parallel battery pack to a series connection, and performing series charging on the battery units. The fast charging method for a parallel battery pack can effectively shorten a charging time.

Abstract: An automatic measuring device includes a platform, a pre-positioned suction nozzle, a reverse suction nozzle, a sensor, and a reflection sheet. The sensor is fixed on a side of the reverse suction nozzle, and the reflection sheet is fixed on a side of the pre-positioned suction nozzle and is located below the sensor. The method includes the following steps: controlling, by the automatic measuring device, a light source to emit light to the reflection sheet; detecting, by the sensor, a measurement value of the reflection sheet; determining, by the automatic measuring device, a change curve of a measurement value and a height according to a material of the reflection sheet; finding, by the automatic measuring device from the change curve, a height value corresponding to the measurement value; and determining, by the automatic measuring device according to the height value, whether the transfer and handoff platform can pass examination.

Abstract: Exoskeletal devices or sleeves that can be used with the delivery tube of an applicator device to help dispense fluids, typically flowable biocompatible materials such as hemostatic agents, adhesives, or sealants, onto specific sites in the human body for a medical reason are disclosed. The exoskeletal devices or sleeves are rigid, pre-shaped, and snappably or slidably affixed to the delivery tube. The exoskeletal devices or sleeves do not come into contact with the flowable biocompatible fluid being dispensed, and they can be placed at any position along the delivery tube to address different application situations. Once the exoskeletal device or sleeve is in place, it can optionally be locked onto the delivery tube to prevent further sliding under stresses when pushed against tissue. Multiple exoskeletal devices or sleeves can also be used to achieve more complicated shapes for hard-to-reach anatomical sites.

Abstract: Methods, compositions, and articles of manufacture for alkane activation with single- or bi-metallic catalysts on crystalline mixed oxide supports.

Abstract: A method for detecting a battery state of health includes a current and a voltage are measured twice in a period of time; corresponding model algorithms are selected according to the measured current values; corresponding battery open circuit voltage values and battery state of charge values at a start time and an end time of the period are obtained based on the model algorithms; a battery capacity difference that indicates a present battery retention capacity and a battery capacity difference that indicates a future battery retention capacity are calculated; and a battery state of health value is calculated when impact of a measured battery temperature value is considered.

Abstract: The present invention is directed to a hemostatic or tissue sealing material having (a) a peptide having a sequence SEQ ID NO: 1 or an amino acid analog sequence thereof, and (b) a scaffold for said peptide or amino acid analogue sequence. The scaffold is preferably hemostatic, such as a natural or genetically engineered absorbable polymer, a synthetic absorbable polymer, or combinations thereof. The natural or genetically engineered absorbable polymers can be selected from the group consisting of a protein, a polysaccharide, or combinations thereof.

Abstract: The present invention is directed to hemostatic material containing compacted ORC powder comprising particles having an average aspect ratio from about 1 to about 18, wherein said compacted ORC powder have preferably been processed in a compaction device, such as a ball milled ORC powder. The present invention further relates to methods of making the hemostatic material and a method of treating a wound by applying the hemostatic powder onto and/or into the wound of a patient.

Abstract: The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.

Abstract: Exoskeletal devices or sleeves that can be used with the delivery tube of an applicator device to help dispense fluids, typically flowable biocompatible materials such as hemostatic agents, adhesives, or sealants, onto specific sites in the human body for a medical reason are disclosed. The exoskeletal devices or sleeves are rigid, pre-shaped, and snappably or slidably affixed to the delivery tube. The exoskeletal devices or sleeves do not come into contact with the flowable biocompatible fluid being dispensed, and they can be placed at any position along the delivery tube to address different application situations. Once the exoskeletal device or sleeve is in place, it can optionally be locked onto the delivery tube to prevent further sliding under stresses when pushed against tissue. Multiple exoskeletal devices or sleeves can also be used to achieve more complicated shapes for hard-to-reach anatomical sites.

Abstract: The present invention is directed to a hemostatic or tissue sealing material having (a) a peptide having a sequence SEQ ID NO: 1 or an amino acid analog sequence thereof, and (b) a scaffold for said peptide or amino acid analogue sequence. The scaffold is preferably hemostatic, such as a natural or genetically engineered absorbable polymer, a synthetic absorbable polymer, or combinations thereof. The natural or genetically engineered absorbable polymers can be selected from the group consisting of a protein, a polysaccharide, or combinations thereof.

Abstract: The present invention is directed to a hemostatic or tissue sealing material having (a) a peptide having a sequence SEQ ID NO: 1 or an amino acid analog sequence thereof, and (b) a scaffold for said peptide or amino acid analog sequence. The scaffold is preferably hemostatic, such as a natural or genetically engineered absorbable polymer, a synthetic absorbable polymer, or combinations thereof. The natural or genetically engineered absorbable polymers can be selected from the group consisting of a protein, a polysaccharide, or combinations thereof.

Abstract: The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.

Abstract: The present invention is directed to hemostatic material containing compacted ORC powder comprising particles having an average aspect ratio from about 1 to about 18, wherein said compacted ORC powder have preferably been processed in a compaction device, such as a ball milled ORC powder. The present invention further relates to methods of making the hemostatic material and a method of treating a wound by applying the hemostatic powder onto and/or into the wound of a patient.

Abstract: The present invention is directed to hemostatic material containing compacted ORC powder comprising particles having an average aspect ratio from about 1 to about 18, wherein said compacted ORC powder have preferably been processed in a compaction device, such as a ball milled ORC powder. The present invention further relates to methods of making the hemostatic material and a method of treating a wound by applying the hemostatic powder onto and/or into the wound of a patient.